RBC Capital reiterated coverage on SelectQuote with a new price target
$SLQT
Specialty Insurers
Finance
RBC Capital reiterated coverage of SelectQuote with a rating of Sector Perform and set a new price target of $3.00 from $13.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/21/2025 | $2.75 | Hold | Jefferies |
| 9/30/2024 | $4.50 | Buy | Craig Hallum |
| 2/29/2024 | $5.00 | Outperform | Noble Capital Markets |
| 4/1/2022 | $4.00 | Neutral | Credit Suisse |
| 2/8/2022 | $9.00 → $5.00 | Equal Weight | Barclays |
| 2/8/2022 | $13.00 → $3.00 | Sector Perform | RBC Capital |
| 2/8/2022 | $20.00 → $4.00 | Overweight → Neutral | Piper Sandler |
| 2/8/2022 | $14.00 → $4.00 | Outperform → Neutral | Credit Suisse |
Jefferies initiated coverage of SelectQuote with a rating of Hold and set a new price target of $2.75
Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50
Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00
8-K - SelectQuote, Inc. (0001794783) (Filer)
SCHEDULE 13G - SelectQuote, Inc. (0001794783) (Subject)
8-K - SelectQuote, Inc. (0001794783) (Filer)
Fourth Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $345.1 million Net income of $12.9 million Adjusted EBITDA* of $2.7 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.650 billion to $1.750 billion Adjusted EBITDA* expected in a range of $120 million to $150 million Fourth Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $82.5 million Adjusted EBITDA* of $7.7 million Approved Medicare Advantage policies of 85,344 Healthcare Services Revenue of $214.0 million Adjusted EBITDA* of $11.9 million 108,018 SelectRx members Life Revenue of $48.0 million Adjusted EBITDA* of $6
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fourth quarter and full year 2025 financial results before market open on Thursday, August 21, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (August 21, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I547808. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes
SelectQuote, Inc. (NYSE:SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with a regional health plan that demonstrated over 90% adherence, strengthening HEDIS Star ratings across the triple-weighted cholesterol, diabetes and hypertension measures. The Company plans to expand to additional payers this calendar year a
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur
Fourth Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $345.1 million Net income of $12.9 million Adjusted EBITDA* of $2.7 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.650 billion to $1.750 billion Adjusted EBITDA* expected in a range of $120 million to $150 million Fourth Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $82.5 million Adjusted EBITDA* of $7.7 million Approved Medicare Advantage policies of 85,344 Healthcare Services Revenue of $214.0 million Adjusted EBITDA* of $11.9 million 108,018 SelectRx members Life Revenue of $48.0 million Adjusted EBITDA* of $6
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fourth quarter and full year 2025 financial results before market open on Thursday, August 21, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (August 21, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I547808. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes
Third Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $408.2 million Net income of $26.0 million Adjusted EBITDA* of $37.7 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(1) million to $28 million Adjusted EBITDA* expected in a range of $115 million to $140 million Third Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $169.4 million Adjusted EBITDA* of $45.7 million Approved Medicare Advantage policies of 168,001 Healthcare Services Revenue of $189.6 million Adjusted EBITDA* of $6.4 million 105,523 SelectRx members Li
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)